MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD. (Q38887255)

7 September 2017

MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD. (English)

1 reference

7 September 2017

1 reference

1 reference

1 reference

Jie Chai

1

1 reference

7 September 2017

Wei Dong

2

1 reference

7 September 2017

Chao Xie

3

1 reference

7 September 2017

Lin Wang

4

1 reference

7 September 2017

Da-Li Han

5

1 reference

7 September 2017

Shan Wang

6

1 reference

7 September 2017

Hong-Liang Guo

7

1 reference

7 September 2017

Zong-Li Zhang

8

1 reference

7 September 2017

1 March 2015

1 reference

7 September 2017

1 reference

7 September 2017

67

1 reference

7 September 2017

3

1 reference

7 September 2017

191-201

1 reference

7 September 2017

Cancer statistics, 2012

1 reference

Cancer treatment and survivorship statistics, 2012

21 January 2018

1 reference

Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements

21 January 2018

1 reference

Chemotherapy-associated liver injury and its influence on outcome after resection of colorectal liver metastases

21 January 2018

1 reference

Efficacy of capecitabine versus 5-fluorouracil in colorectal and gastric cancers: a meta-analysis of individual data from 6171 patients

21 January 2018

1 reference

Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis

21 January 2018

1 reference

p38α MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance.

21 January 2018

1 reference

Differential clinical benefits of 5-fluorouracil-based adjuvant chemotherapy for patients with stage III colorectal cancer according to CD133 expression status

21 January 2018

1 reference

Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years

21 January 2018

1 reference

Drug resistance-related microRNAs in hematological malignancies: translating basic evidence into therapeutic strategies

21 January 2018

1 reference

Molecular mechanisms underlying the role of microRNAs in the chemoresistance of pancreatic cancer

21 January 2018

1 reference

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

Overexpression of microRNA-122 re-sensitizes 5-FU-resistant colon cancer cells to 5-FU through the inhibition of PKM2 in vitro and in vivo

21 January 2018

1 reference

SNAI2 modulates colorectal cancer 5-fluorouracil sensitivity through miR145 repression

21 January 2018

1 reference

Down-regulation of miR-21 Induces Differentiation of Chemoresistant Colon Cancer Cells and Enhances Susceptibility to Therapeutic Regimens

21 January 2018

1 reference

Real-time quantification of microRNAs by stem-loop RT-PCR

21 January 2018

1 reference

Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer.

21 January 2018

1 reference

MicroRNA expression as risk biomarker of breast cancer metastasis: a pilot retrospective case-cohort study

21 January 2018

1 reference

MicroRNA-494 within an oncogenic microRNA megacluster regulates G1/S transition in liver tumorigenesis through suppression of mutated in colorectal cancer

21 January 2018

1 reference

MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer

21 January 2018

1 reference

miR-494 acts as an anti-oncogene in gastric carcinoma by targeting c-myc

21 January 2018

1 reference

MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation

21 January 2018

1 reference

Overexpression of secretagogin inhibits cell apoptosis and induces chemoresistance in small cell lung cancer under the regulation of miR-494

21 January 2018

1 reference

Implications of dihydropyrimidine dehydrogenase on 5-fluorouracil pharmacogenetics and pharmacogenomics.

21 January 2018

1 reference

Dihydropyrimidine dehydrogenase deficiency, a pharmacogenetic syndrome associated with potentially life-threatening toxicity following 5-fluorouracil administration

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IUB.1361

1 reference

7 September 2017

1 reference